BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26467045)

  • 1. Complete blood counts, liver function tests, and chest x-rays as routine screening in early-stage breast cancer: value added or just cost?
    Louie RJ; Tonneson JE; Gowarty M; Goodney PP; Barth RJ; Rosenkranz KM
    Breast Cancer Res Treat; 2015 Nov; 154(1):99-103. PubMed ID: 26467045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Is the Utility of Routine Complete Blood Count, Liver Function Tests, and Chest X-ray in the Evaluation of Patients with Clinically Node-Negative Breast Cancer?
    Merrill AY; Garland MM; Howard-McNatt M; Isnassuos M; Perry KC; Levine EA
    Am Surg; 2019 Jan; 85(1):29-33. PubMed ID: 30760341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Strategy for Changing Adherence to National Guidelines for Decreasing Laboratory Testing for Early Breast Cancer Patients.
    Hill LA; Vang CA; Kennedy CR; Linebarger JH; Dietrich LL; Parsons BM; Hennessy JL; Theede LM; VanderLei LK; Ramirez LD; Ernst AJ; Landercasper J
    WMJ; 2018 Jun; 117(2):68-72. PubMed ID: 30048575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overuse of Chest CT in Patients With Stage I and II Breast Cancer: An Opportunity to Increase Guidelines Compliance at an NCCN Member Institution.
    Dull B; Linkugel A; Margenthaler JA; Cyr AE
    J Natl Compr Canc Netw; 2017 Jun; 15(6):783-789. PubMed ID: 28596258
    [No Abstract]   [Full Text] [Related]  

  • 5. Baseline staging tests in primary breast cancer: a practice guideline.
    Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
    CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of preoperative staging chest computed tomography to detect asymptomatic lung and liver metastasis in patients with primary breast carcinoma.
    Kim H; Han W; Moon HG; Min J; Ahn SK; Kim TY; Im SA; Oh DY; Han SW; Chie EK; Ha SW; Noh DY
    Breast Cancer Res Treat; 2011 Apr; 126(3):637-41. PubMed ID: 21298335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance testing among survivors of early-stage breast cancer.
    Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
    J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients.
    Han D; Hogeveen S; Sweet Goldstein M; George R; Brezden-Masley C; Hoch J; Haq R; Simmons CE
    Breast Cancer Res Treat; 2012 Feb; 132(1):1-7. PubMed ID: 21947708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The excessive cost of baseline diagnostic imaging in early breast cancer.
    Morris PG; O'Connor M; O'Rafferty C; Sheikh R; Gray J; McDermott R; Boyle T; Kennedy MJ
    Ir Med J; 2009 May; 102(5):149-52. PubMed ID: 19623811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of metastatic screening in early primary breast cancer.
    Barry MC; Thornton F; Murphy M; Younis F; Watson RG
    Ir J Med Sci; 1999; 168(4):248-50. PubMed ID: 10624363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial.
    Kokko R; Hakama M; Holli K
    Breast Cancer Res Treat; 2003 Sep; 81(1):33-9. PubMed ID: 14531495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
    Koolen BB; Vrancken Peeters MJ; Aukema TS; Vogel WV; Oldenburg HS; van der Hage JA; Hoefnagel CA; Stokkel MP; Loo CE; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
    Breast Cancer Res Treat; 2012 Jan; 131(1):117-26. PubMed ID: 21935602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-benefit in the study of the dissemination of stage I and II in breast cancer].
    Camacho J; Barriga C; Escobar P; Seleme N; Schwartz R
    Rev Med Chil; 2003 Feb; 131(2):155-7. PubMed ID: 12708253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline staging of newly diagnosed breast cancer--Kuwait cancer control center experience.
    Abuzallouf S; Motawy M; Thotathil Z
    Med Princ Pract; 2007; 16(1):22-4. PubMed ID: 17159359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging Investigations in Asymptomatic Early Breast Cancer Patients at the Cancer Centre of Southeastern Ontario.
    Kamel D; Youssef V; Hopman WM; Mates M
    Curr Oncol; 2021 Jun; 28(3):2190-2198. PubMed ID: 34204717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma.
    Mouriaux F; Diorio C; Bergeron D; Berchi C; Rousseau A
    Ophthalmology; 2012 Aug; 119(8):1590-5. PubMed ID: 22683062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer.
    Chen EA; Carlson GA; Coughlin BF; Reed WP; Garb JL; Frank JL
    J Clin Oncol; 2000 Oct; 18(20):3503-6. PubMed ID: 11032591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of 6-month interval imaging after benign radiologic-pathologic concordant minimally invasive breast biopsy.
    Manjoros DT; Collett AE; Alberty-Oller JJ; Frazier TG; Barrio AV
    Ann Surg Oncol; 2013 Oct; 20(10):3163-8. PubMed ID: 23975288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.